(19)
(11) EP 3 788 079 A1

(12)

(43) Date of publication:
10.03.2021 Bulletin 2021/10

(21) Application number: 19796462.0

(22) Date of filing: 30.04.2019
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
 C12N 5/10(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/CN2019/085164
(87) International publication number:
WO 2019/210848 (07.11.2019 Gazette 2019/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.05.2018 WO PCT/CN2018/085468

(71) Applicant: Shanghai Epimab Biotherapeutics Co., Ltd.
Shanghai 201112 (CN)

(72) Inventors:
  • WU, Xuan
    Shanghai 201210 (CN)
  • GONG, Shiyong
    Shanghai 201210 (CN)
  • WU, Chengbin
    Shanghai 201210 (CN)

(74) Representative: Bianchetti Bracco Minoja S.r.l. 
Via Plinio, 63
20129 Milano
20129 Milano (IT)

   


(54) HIGH AFFINITY ANTIBODIES TO PD-1 AND LAG-3 AND BISPECIFIC BINDING PROTEINS MADE THEREFROM